Team:USC

From 2011.igem.org

(Difference between revisions)
 
(2 intermediate revisions not shown)
Line 34: Line 34:
<table>
<table>
<tr>
<tr>
-
<h1 style="font-family:Verdana;font-weight:700;">E. Curi</h1>
+
<h1 style="font-family:Verdana;font-weight:700;">E. curi</h1>
</tr>
</tr>
Line 54: Line 54:
<td>
<td>
<p style="font-family:Verdana;">
<p style="font-family:Verdana;">
-
To begin, our project will utilize a synthetic version of CRISPR generated by inserting an engineered spacer that matches the DNA sequence coded within an E. coli expression plasmid. We will first test the synthetic CRISPR array against E. coli harboring a tetR regulated tetO::GFP system. We anticipate that the CRISPER tetR targeted spacer will destroy the tetR plasmid, relieving the inhibition of the tetO locus and facilitating the expression of GFP. In the near future, we hope to use the synthetic CRISPR system as a biological tool, combining it with other BioBricks and parts for use in many applications that will impact health and medicine, biotechnology, molecular biology and genetics.
+
We synthesized a version of CRISPR encoding a spacer that matches the GFP DNA sequence. We tested the synthetic CRISPR array against E.coli harboring a tetO::GFP plasmid that confers ampicillin resistance. Activation of CRISPER-GFP destroys the GFP-containing plasmid restoring the bacterial host's sensitivity to ampicillin. We will use the synthetic CRISPR system as a biological tool, combining it with other BioBricks for use in applications that will impact health and medicine, biotechnology, molecular biology, and genetics.
</p>
</p>
</td>
</td>
Line 64: Line 64:
<h1 style="font-family:Verdana;font-weight:700;">Our Sponsors</h1>
<h1 style="font-family:Verdana;font-weight:700;">Our Sponsors</h1>
{|border="1px" align="center" style="text-align:center;"
{|border="1px" align="center" style="text-align:center;"
-
|[[File:curranlab.jpg | 200px | ]] || Curran Laboratory at the University of Southern California
+
|[[File:curranlab.jpg | 150px | ]] || Curran Laboratory at the USC School of Gerontology
|-
|-
-
|[[File:Labofmicriobio wageningen.gif | 300px | ]] || Brouns Laboratory at the University of Wageningen
+
|[[File:Labofmicriobio wageningen.gif | 400px | ]] || Brouns Laboratory at the University of Wageningen
|-
|-
|[[File:IDTLogo2010.png | 200px | ]] || Integrated DNA Technologies
|[[File:IDTLogo2010.png | 200px | ]] || Integrated DNA Technologies

Latest revision as of 04:11, 29 September 2011

USC Banner.jpg


E. curi

Bacteria protect their genome and remove foreign DNA elements through the use of the clustered, regularly interspaced short palindromic repeat (CRISPR) system. Recently discovered, this defense mechanism can protect microorganisms against bacteriaphages. The CRISPR system comprises a transcribed locus of repeats and spacers that is activated and made functional via a family of CAS proteins. The CRISPR repeats are short DNA sequences that are almost identical in size and sequence. Between a pair of repeats is a spacer, which if complementary to a DNA element of the invading bacteriaphage, facilitates the destruction of that sequence from the bacterial cell. As such, the CRISPR/CAS system is a primitive biological defense mechanism, similar in many ways to the process of adaptive immunity in eukaryotic immune systems. Plasmids, which are commonly used in molecular biology are also the source of horizontal gene transfer in the wild and facilitate the spread of antibiotic resistant genes among microorganisms. These plasmids can contain unique DNA sequences that could be targeted by the CRISPR/CAS system. We intend to exploit the CRISPR/CAS system to engineer a mechanism of plasmid curing and deactivation of antibiotic resistance genes in E. coli.

CRISPRworks.png

We synthesized a version of CRISPR encoding a spacer that matches the GFP DNA sequence. We tested the synthetic CRISPR array against E.coli harboring a tetO::GFP plasmid that confers ampicillin resistance. Activation of CRISPER-GFP destroys the GFP-containing plasmid restoring the bacterial host's sensitivity to ampicillin. We will use the synthetic CRISPR system as a biological tool, combining it with other BioBricks for use in applications that will impact health and medicine, biotechnology, molecular biology, and genetics.

Our Sponsors

Curranlab.jpg Curran Laboratory at the USC School of Gerontology
File:Labofmicriobio wageningen.gif Brouns Laboratory at the University of Wageningen
IDTLogo2010.png Integrated DNA Technologies
Dornsife.jpg David and Dana Dornsife College of Arts and Sciences
File:Viterbi.gif Viterbi School of Engineering
Retrieved from "http://2011.igem.org/Team:USC"